Skip to main content

Aldeyra Therapeutics, Inc.

ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001341235

No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Aldeyra Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ALDX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders126122−4
Shares37.9M34.1M−3.76M (−9.9%)
Value$215.5M$130.8M−$84.8M (−39.3%)

New holders (20)

Institutions that held Aldeyra Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ALDX in Q2 2025
InstitutionSharesValue% of portfolio
Walleye Capital LLC155,609$596.0K0.01%
Gsa Capital Partners LLP73,296$281.0K0.02%
Cerity Partners LLC36,577$140.1K0.00%
Essential Partners LLC34,177$130.9K0.05%
Cubist Systematic Strategies, LLC29,967$114.8K0.00%
Ameriprise Financial Inc26,263$100.6K0.00%
Mariner, LLC22,413$85.8K0.00%
Brighton Jones LLC17,899$68.6K0.00%
Pallas Capital Advisors LLC17,762$68.0K0.00%
Los Angeles Capital Management LLC16,320$62.5K0.00%
Corton Capital Inc.14,940$57.2K0.07%
Citadel Advisors LLC12,454$47.7K0.00%
King Wealth12,100$46.0K0.01%
Two Sigma Securities, LLC11,002$42.1K0.01%
Inspirion Wealth Advisors, LLC10,000$38.3K0.01%
Public Employees Retirement System of Ohio6,500$24.9K0.00%
IFP Advisors, Inc1,404$5.38K0.00%
Kozak & Associates, Inc.1,000$4.52K0.00%
Allworth Financial LP1,063$4.07K0.00%
Rothschild Investment LLC85$3260.00%

Sold out (24)

Institutions that held Aldeyra Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.